<?xml version="1.0" ?>
<rss version="2.0">
  <channel>
    <title>Gene Therapy Net - What's new</title>
	<link>http://www.genetherapynet.com</link>
	<language>en-us</language> 
	<copyright>Copyright 2007-2008 Gene Therapy Net</copyright> 
    <description>Gene Therapy Net site updates, including conference announcements and the latest special news items. 
</description>
 	 <pubDate>Sat, 1 Nov 2008 16:26:00 GMT</pubDate> 
  	<lastBuildDate>Sat, 1 Nov 2008 16:26:00 GMT</lastBuildDate> 
    <item> 
       <title>Viral vector section update</title>
       <link>http://www.genetherapynet.com/viralvectors.html</link>  
	   <pubDate>Sat, 1 Nov 2008 16:26:00 GMT</pubDate> 
       <description>A description of the following viral gene therapy vectors has been added: Alphaviruses, Herpesviruses and Vaccinia viruses.</description>
    </item> 
    <item> 
       <title>Conference update: International Society for Cell and Gene Therapy of Cancer (ISCGT) Congress</title>
       <link>http://www.genetherapynet.com/conferences.html</link>  
	   <pubDate>Thu, 15 Oct 2008 21:35:00 GMT</pubDate> 
       <description>3 - 4 September 2009, International Society for Cell and Gene Therapy of Cancer (ISCGT) Congress</description>
    </item> 
    <item> 
       <title>Conference update: The Ethics of Gene Therapy of Inherited diseases</title>
       <link>http://www.genetherapynet.com/conferences.html</link>  
	   <pubDate>Fri, 10 Oct 2008 12:34:00 GMT</pubDate> 
       <description>13 November 2008, The Ethics of Gene Therapy of Inherited diseases - CONSERT Symposium</description>
    </item> 
    <item> 
       <title>Gene Therapy Net Press Release</title>
       <link>http://www.medicalnewstoday.com/articles/121852.php</link>  
	   <pubDate>Fri, 19 Sep 2008 20:00:00 GMT</pubDate> 
       <description>Gene Therapy Enters New Success Story Online - Scattered Gene Therapy Information Collected On Comprehensive Website</description>
    </item> 
    <item> 
       <title>Conference update: International Symposium on Gene Doping in Sports</title>
       <link>http://www.genetherapynet.com/conferences.html</link>  
	   <pubDate>Fri, 19 Sep 2008 20:00:00 GMT</pubDate> 
       <description>25 - 27 October 2008, International Symposium on Gene Doping in Sports</description>
    </item> 
    <item> 
       <title>Company update</title>
       <link>http://www.genetherapynet.com/companies.html</link>  
	   <pubDate>Fri, 19 Sep 2008 20:00:00 GMT</pubDate> 
       <description>Asklepios BioPharmaceutical Inc. and NanoCor Therapeutics, Inc.</description>
    </item> 
    <item> 
       <title>News: Gene Therapy For Blindness Improves Vision, Safety Study Indicates.</title>
       <link>http://www.genetherapynet.com/news.html</link>  
	   <pubDate>Mon, 15 Sep 2008 16:50:00 GMT</pubDate> 
       <description>All three people who received gene therapy at the University of Florida to treat a rare, incurable form of blindness have regained some of their vision, according to a paper published online today in Human Gene Therapy. 
The patients with a type of hereditary blindness called Leber congenital amaurosis type 2, volunteered to test the safety of an experimental gene-transfer technique in a phase 1 clinical research study. In this form of LCA disease, photoreceptor cells cannot respond to light because a gene called RPE65 does not properly produce a protein necessary for healthy vision. In the study, researchers used an adeno-associated virus to deliver RPE65 to a small area of the retina. Not only were there no ill effects other than routine postsurgical soreness, the subjects said the vision in their treated eyes was slightly improved in dim lighting conditions.</description>
    </item> 
    <item> 
       <title>Conference update: 'Gene Therapy: Exchange Opportunities between East and West'</title>
       <link>http://www.genetherapynet.com/china.html#ISCGT</link>  
	   <pubDate>Sun, 14 Sep 2008 10:00:00 GMT</pubDate> 
       <description>19 – 22 September, International Society for Cell and Gene Therapy of Cancer (ISCGT) Congress, Shijiazhuang, China. Additional Informal Breakfast session September 21, 2008, 7 AM entitled Gene Therapy: Exchange Opportunities between East and West.</description>
    </item> 
	<item> 
       <title>China and Gene therapy section updated</title>
       <link>http://www.genetherapynet.com/china.html</link>  
	   <pubDate>Sun, 14 Sep 2008 10:00:00 GMT</pubDate> 
       <description>Chinese biotechnology companies added, as well as useful links and a list of funding organisations involved in promoting research co-operation with China.</description>
    </item> 
    <item> 
       <title>Conference update: International Society for Cellular Therapy (ISCT) 15th Annual Meeting</title>
       <link>http://www.genetherapynet.com/conferences.html</link>  
	   <pubDate>Thu, 11 Sep 2008 20:00:00 GMT</pubDate> 
       <description>2 – 6 May 2009, International Society for Cellular Therapy (ISCT) 15th Annual Meeting</description>
    </item> 
	<item> 
       <title>Conference update: 8th Annual Somatic Cell Therapy Symposium (ISCT)</title>
       <link>http://www.genetherapynet.com/conferences.html</link>  
	   <pubDate>Thu, 11 Sep 2008 20:00:00 GMT</pubDate> 
       <description>22 - 24 September 2008, 8th Annual Somatic Cell Therapy Symposium (ISCT)</description>
    </item> 
    <item> 
       <title>Conference update: DNA Vaccines 2008</title>
       <link>http://www.genetherapynet.com/conferences.html</link>  
	   <pubDate>Mon, 8 Sep 2008 22:00:00 GMT</pubDate> 
       <description>5 - 7 December 2008, DNA Vaccines 2008</description>
    </item> 
    <item> 
       <title>Gene Doping</title>
       <link>http://www.genetherapynet.com/genetherapy.html#genedoping</link>  
	   <pubDate>Sun, 31 Aug 2008 17:00:00 GMT</pubDate> 
       <description>New information added about gene doping: the non-therapeutic use of cells, genes, genetic elements, or of the modulation of gene expression, having the capacity to improve athletic performance</description>
    </item>
    <item> 
       <title>Gene Therapy Net banners</title>
       <link>http://www.genetherapynet.com/banner.html</link>  
	   <pubDate>Fri, 29 Aug 2008 20:00:00 GMT</pubDate> 
       <description>Link to Gene Therapy Net by using one of the images or buttons HTML code onto your page</description>
    </item>
    <item> 
       <title>Conference update: Advanced Therapy Medicinal Product Development and Regenerative Medicine</title>
       <link>http://www.genetherapynet.com/conferences.html</link>  
	   <pubDate>Fri, 22 Aug 2008 22:00:00 GMT</pubDate> 
       <description>25 - 26 november 2008, Advanced Therapy Medicinal Product Development and Regenerative Medicine, Paul-Ehrlich-Institut, Langen, Germany</description>
    </item> 
    <item> 
       <title>Conference update: BIT's 2nd Annual World Congress of Gene 2008</title>
       <link>http://www.genetherapynet.com/conferences.html</link>  
	   <pubDate>Fri, 22 Aug 2008 22:00:00 GMT</pubDate> 
       <description>5 - 7 December 2008, BIT's 2nd Annual World Congress of Gene 2008, Guangzhou, China</description>
    </item> 
    <item> 
       <title>Gene therapy in China</title>
       <link>http://www.genetherapynet.com/china.html</link>  
	   <pubDate>Wed, 20 Aug 2008 13:00:00 GMT</pubDate> 
       <description>Link update: Video - Cancer Gene therapy treatment in China</description>
    </item> 
    <item> 
       <title>Gene therapy patient information updated</title>
       <link>http://www.genetherapynet.com/patients.html</link>  
	   <pubDate>Tue, 19 Aug 2008 13:00:00 GMT</pubDate> 
       <description>Video update: First gene therapy trial for SCID patient, Gene therapy for Muscular Dystrophy and Individualized Drugs and Gene Therapy. Including update of sources</description>
	</item>
    <item> 
       <title>What is gene therapy section updated</title>
       <link>http://www.genetherapynet.com/patients.html</link>  
	   <pubDate>Tue, 19 Aug 2008 13:00:00 GMT</pubDate> 
       <description>Video update: Very informative lectures about what is gene therapy and recombinant DNA</description>
    </item>  
    <item>
       <title>Conference update: Australasian Gene Therapy Society (AGTS) 6th Meeting</title>
       <link>http://www.genetherapynet.com/conferences.html</link>  
	   <pubDate>Wed, 13 Aug 2008 13:00:00 GMT</pubDate> 
       <description>29 April - 1 May 2009, Australasian Gene Therapy Society (AGTS) 6th Meeting, Sydney, Australia</description>
    </item>
    <item>
       <title>Gene Therapy Jobs - new service</title>
       <link>http://www.genetherapynet.com/genetherapyjobs.html</link>  
	   <pubDate>Fri, 8 Aug 2008 13:00:00 GMT</pubDate> 
       <description>Selection of latest gene therapy jobs found at NewScientist Jobs and Juju Jobs</description>
    </item>
    <item>
       <title>Conference update: The 15th Annual Meeting of the Japan Society of Gene Therapy (JSGT)</title>
       <link>http://www.genetherapynet.com/conferences.html</link>  
	   <pubDate>Sat, 2 Aug 2008 13:00:00 GMT</pubDate> 
       <description>9 - 11 July 2009, The 15th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Osaka, Japan</description>
    </item>
    <item>
       <title>Clinical Trials section updated</title>
       <link>http://www.genetherapynet.com/clinicaltrialsgov.html</link>  
	   <pubDate>Tue, 29 Jul 2008 13:00:00 GMT</pubDate> 
       <description>Overview of studies received in the last 60 days at ClinicalTrials.gov, including a search utility to seach specific clinical gene therapy trials</description>
    </item>
    <item>
       <title>Introgen Submits ADVEXIN® Regulatory Applications in the U.S. and Europe</title>
       <link>http://www.genetherapynet.com/news.html</link>  
	   <pubDate>Tue, 1 Jul 2008 13:00:00 GMT</pubDate> 
       <description>Introgen Therapeutics, Inc. submitted a Biologics License Application (BLA) to the FDA requesting marketing approval for ADVEXIN p53 therapy to treat recurrent, refractory head and neck cancer. Simultaneously, Gendux Molecular Limited, an Introgen subsidiary, submitted a Marketing Authorization Application to the EMEA for the same indication. ADVEXIN represents the first of a new class of tumor suppressor cancer therapy and is the first of its kind to be submitted for regulatory approval in the United States and Europe </description>
    </item>
  </channel>
</rss> 
 
